5DS — MegaChem Cashflow Statement
0.000.00%
- SG$46.66m
- SG$60.94m
- SG$128.84m
- 85
- 86
- 74
- 96
Annual cashflow statement for MegaChem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.26 | 7.99 | 6.07 | -5.34 | 8.69 |
Depreciation | |||||
Non-Cash Items | -0.372 | 0.277 | 1.75 | 10.2 | 1.59 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.002 | -17.3 | -12.1 | 9.53 | -0.53 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 6.13 | -7.86 | -2.97 | 15.8 | 11 |
Capital Expenditures | -2.82 | -3.42 | -1.66 | -1.19 | -2.74 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.469 | 0.633 | 1.65 | -0.72 | 0.321 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.35 | -2.79 | -0.012 | -1.91 | -2.41 |
Financing Cash Flow Items | -0.721 | -0.636 | -1.13 | -1.97 | -2.03 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.77 | 5.81 | 3.15 | -11.6 | -6.51 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.03 | -4.81 | -0.158 | 2.07 | 2.27 |